Joseph Kim

Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.

P. Sharma, P. Ott, J. Rosenberg, 2016 .

A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer (UBC).

P. Hegde, T. Powles, H. Burris, 2015 .

Immune Analysis of Radium‐223 in Patients With Metastatic Prostate Cancer

M. Shin, I. Kang, D. Petrylak, 2017, Clinical genitourinary cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer

P. Choyke, H. Parnes, B. Turkbey, 2016, The Journal of Nuclear Medicine.

A Potent Immunomodulatory Compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole Acetic Acid, Prevents Spontaneous and Accelerated Forms of Autoimmune Diabetes in NOD Mice and Inhibits the Immunoinflammatory Diabetes Induced by Multiple Low Doses of Streptozotocin in CBA/H Mice

F. Nicoletti, K. Mangano, M. Fresta, 2007, Journal of Pharmacology and Experimental Therapeutics.